Zakia Belhadj

608 total citations
10 papers, 492 citations indexed

About

Zakia Belhadj is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Zakia Belhadj has authored 10 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Biomedical Engineering and 3 papers in Biomaterials. Recurrent topics in Zakia Belhadj's work include Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Extracellular vesicles in disease (3 papers). Zakia Belhadj is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Extracellular vesicles in disease (3 papers). Zakia Belhadj collaborates with scholars based in China and United States. Zakia Belhadj's co-authors include Bing He, Xueqing Wang, Wenbing Dai, Qiang Zhang, Hua Zhang, Hailiang Deng, Siyang Song, Qiang Zhang, Yujie Shi and Xiaoli Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Oncotarget.

In The Last Decade

Zakia Belhadj

10 papers receiving 485 citations

Peers

Zakia Belhadj

MB

BIOMA

BE

CR

IMMUN

Ayşe Gülten Kantarcı Türkiye

Xinchun Xu China

Emma McErlean United Kingdom

Gülşah Erel‐Akbaba Türkiye

Hannah J. Vaughan United States

Luke van der Koog Netherlands

Eriya Kenjo Japan

Siyang Song China

Rayhaneh Afjei United States

Sukyung Song South Korea

Ayşe Gülten Kantarcı Türkiye

Zakia Belhadj

256 ×0.9

MB

145 ×0.9

BIOMA

141 ×0.9

BE

63 ×0.7

CR

64 ×0.8

IMMUN

Citations per year, relative to Zakia Belhadj Zakia Belhadj (= 1×) peers Ayşe Gülten Kantarcı

Countries citing papers authored by Zakia Belhadj

Since Specialization

Citations

This map shows the geographic impact of Zakia Belhadj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zakia Belhadj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zakia Belhadj more than expected).

Fields of papers citing papers by Zakia Belhadj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zakia Belhadj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zakia Belhadj. The network helps show where Zakia Belhadj may publish in the future.

Co-authorship network of co-authors of Zakia Belhadj

This figure shows the co-authorship network connecting the top 25 collaborators of Zakia Belhadj. A scholar is included among the top collaborators of Zakia Belhadj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zakia Belhadj. Zakia Belhadj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Belhadj, Zakia, et al.. (2024). Characterization of a deazaflavin analog as a potent inhibitor of multidrug resistance-associated protein 1. Biomedicine & Pharmacotherapy. 178. 117167–117167. 3 indexed citations

2.

Belhadj, Zakia, et al.. (2023). Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles. SHILAP Revista de lepidopterología. 1(2). 48 indexed citations

3.

Belhadj, Zakia, et al.. (2023). Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles. 1(2). 3 indexed citations

4.

Belhadj, Zakia, et al.. (2023). Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation. European Journal of Pharmaceutical Sciences. 193. 106686–106686. 1 indexed citations

5.

Liu, Yang, et al.. (2023). Virus-like particle-based nanocarriers as an emerging platform for drug delivery. Journal of drug targeting. 31(5). 433–455. 14 indexed citations

6.

Shi, Yujie, Lu An, Xiangyu Wang, et al.. (2021). A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharmaceutica Sinica B. 11(8). 2396–2415. 102 indexed citations

7.

Belhadj, Zakia, Bing He, Jijun Fu, et al.. (2020). <p>Regulating Interactions Between Targeted Nanocarriers and Mononuclear Phagocyte System via an Esomeprazole-Based Preconditioning Strategy</p>. International Journal of Nanomedicine. Volume 15. 6385–6399. 14 indexed citations

8.

Belhadj, Zakia, Bing He, Hailiang Deng, et al.. (2020). A combined “eat me/don't eat me” strategy based on extracellular vesicles for anticancer nanomedicine. Journal of Extracellular Vesicles. 9(1). 1806444–1806444. 165 indexed citations

9.

Belhadj, Zakia, Ying Man, Xuefeng Hu, et al.. (2017). Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Journal of Controlled Release. 255. 132–141. 78 indexed citations

10.

Belhadj, Zakia, Changyou Zhan, Ying Man, et al.. (2017). Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment. Oncotarget. 8(40). 66889–66900. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact